# Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects

> **NCT06345677** · NA · COMPLETED · sponsor: **Vensica Therapeutics Ltd.** · enrollment: 48 (actual)

## Conditions studied

- Overactive Bladder

## Interventions

- **COMBINATION_PRODUCT:** ViXe Xombination
- **COMBINATION_PRODUCT:** Placebo + Sham

## Key facts

- **NCT ID:** NCT06345677
- **Lead sponsor:** Vensica Therapeutics Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-06-09
- **Primary completion:** 2024-02-01
- **Final completion:** 2024-02-01
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2024-04-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06345677

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06345677, "Clinical Trial for the Assessment of Safety, Usability and Efficacy of the Vixe Combination for OAB in Female Subjects". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06345677. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*